Antiviral Effect of Water Soluble Substance from Elfvingia applanata Alone and in Combinations with Interferons Against Vesicular Stomatitis Virus (New Jersey Serotype)

잔나비걸상 수용성물질의 Vesicular Stomatitis Virus(New Jersey Serotype)에 대한 항바이러스작용과 Interferon과의 병용효과

  • Rym, Kyo-Hwan (College of Pharmacy, Chungbuk National University) ;
  • Eo, Seong-Kug (College of Pharmacy, Chungbuk National University) ;
  • Kim, Young-So (College of Pharmacy, Chungbuk National University) ;
  • Lim, Jai-Yun (College of Natural Science, Chungbuk National University) ;
  • Han, Seong-Sun (College of Pharmacy, Chungbuk National University)
  • Published : 1999.04.30

Abstract

In order to find less toxic antiviral agents from Basidiomycetes, EA, the water soluble substance, was prepared from the carpophores of Elfvingia applanata (Pers.) Karst. Antiviral activity of EA against vesicular stomatitis virus [New Jersey serotype, VSV(NJ)] was examined in Vero cells using plaque reduction assay in vitro. And the combined antiviral effects of EA with interferon (IFN) alpha and gamma were examined on the multiplication of VSV(NJ). EA caused a concentration-dependent reduction in the plaque formation of VSV(NJ) with 50% effective concentration $(EC_{50})$ of 2.10 mg/ml. The results of combination assay were evaluated by the combination index (CI) that was analysed by the multiple drug effect analysis. The combination of EA with IFN alpha showed more potent effect with CI values of $0.87{\sim}1.59$ for 50%, 70% and 90% effective levels than that with INF gamma with CI values of $1.05{\sim}2.03$.

잔나비걸상 Elfvingia applananta 자실체의 수용성물질 EA의 vesicular stomatitis virus[New Jersey serotype, VSV(NJ)]에 대한 항바이러스효과를 plaque reduction assay에 따라 실험한 결과 EA는 용량의존적으로 plaque 형성을 억제하였으며 $EC_{50}$는 2.10 mg/ml이었다. 단백질성 항바이러스제인 interferon(IFN)과 EA와의 병용시험 결과 f(a)가 0.50에서 0.90인 유효농도범위에서 IFN alpha와 병용시 f(a)의 값이 커짐에 따라 상가작용 내지는 길항작용을 나타내었으며, IFN gamma와의 병용시에는 길항작용을 나타내었다. 따라서 IFN alpha와의 병용시 f(a)가 0.50내지 0.70의 유효농도 범위에서 상가효과가 있다.

Keywords

References

  1. The interferon system; A current review to 1987 Baron, S.;Dianzani, F.;Stanton, G.J.;Fleischmann, W.R. Jr.
  2. Adv. Enzyme Regul. v.22 Quantitative analysis of dose-effect relationship; The combined effects of multiple drugs or enzyme inhibitor Chou, T.C.;Talalay, P.
  3. J. Antimicrob. Chemother v.18 General aspects of virus resistance with special reference to herpes simplex virus Coen, E.M.
  4. Arch. Virology v.51 An improved plaque-assay for varicella virus Hondo, R.;Shibuta, H.;Matumoto, M.
  5. Acta Microbiol. Pol. v.28 no.4 Fungal nucleic acids as interferon inducers Kandefer, S.M.;Kawecki, Z.;Guz, M.
  6. Yakhak Hoeji v.38 no.6 Effect of Elfvingia applanata extract on the acute toxicity in mice Kim, Y.S.;Kang, J.K.;Lee, C.K.;Han, S.S.
  7. Virus plaquereduction assay for Interferon; Microplaque and regular microplaque reduction assay. 78;Methods in Enzymology Langford, M.P.;Weight, D.A.;Pegstka, S.(ed.)
  8. Shizuoka Daigaku Nogakubu Kenkyu Hokoku v.31 Hostmediated antitumor polysaccharides IV. Fractionation, structural study and antitumor activity of heterogalactans isolated from the fruit bodies of Ganoderma applanatum and Fomitopsis pinicola Mizuno, T.;Hayashi, K.;Iwasaki, Y.;Shitano, A.;Arakawa, M.;Shinkai, K.;Shimizu, M.;Tanaka, M.
  9. Microbiol. Immunol. v.23 no.6 Effect of polysaccharides from Ganoderma applanatum on immune responses I. Enhancing effect on the induction of delayed hypersensitivity in mice Nakashima, S.;Umeda, Y.;Kanada, T.
  10. Vesicular stomatitis virus;Encyclopedia of Virology III Nichol. S.T.;Webster, R.G.;Granoff, A.
  11. Phytochemistry v.28 no.1 Bitter triterpenoids from the fungus Ganoderma applanatum Nishitoba, T.;Goto, S.;Sato, H.;Sakamura, S.
  12. Colored Fungi of Korea Park, W.H.
  13. Combined therapeutic modalities for viruses-rationale and clinical potential;Molecular Mechanism of Chemotherapeutic Synergism, Potentiation and Antagonism Schinazi, R.F.;Chou, T.C.(ed.);Rideout, D.C.(ed.)
  14. Cancer Res. v.48 Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines Scubiero, D.A.;Shoemaker, R.H.;Paull, K.D.;Monks, A.;Tierney, S.;Nofziger, T.H.;Currens, M.J.;Seniff, D.;Boyd, M.R.
  15. Mechanism of action and pharmacology: chemical agents;Antiviral Agents and Viral Diseases of Man Shannon, W.M.;Glasso, G.J.(ed.);Merigan, T.C.(ed.);Buchanon, R.A.(ed.)
  16. Antiviral Chem. Chemother v.3 no.3 Synergistic inhibition of human immunodeficiency virus type I in vitro by interferon alpha and coumermycin A1 Tachedjian, G.;Tyssen, D.;Jardine, D.;Locarnini, S.;Birch, C.
  17. Carbohydr. Res. v.115 no.1 Isolation and characterization of antitumor active ${\beta}$-D-glucan from the fruit bodies of Ganoderma applanatum Usui, T.;Iwasaki, Y.;Mizuno, T.;Tanaka, M.;Shinkai, K.;Arakawa, M.